Gene · 406920
Papers2,391
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,391
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MiR-20b Tissue Expression Level Displays the Diagnostic Value in Papillary Thyroid Carcinoma. | Med J Islam Repub Iran | 2023 | 38021380 | PubTator, text mining | PubMed |
| Nanoparticles and Mesenchymal Stem Cell (MSC) Therapy for Cancer Treatment: Focus on Nanocarriers and a si-RNA CXCR4 Chemokine Blocker as Strategies for Tumor Eradication In Vitro and In Vivo. | Micromachines (Basel) | 2023 | 38004925 | PubTator, text mining | PubMed |
| Characterization of a miRNA Signature with Enhanced Diagnostic and Prognostic Power for Patients with Bladder Carcinoma. | Int J Mol Sci | 2023 | 38003433 | PubTator, text mining | PubMed |
| Non-Coding RNAs in Human Cancer and Other Diseases: Overview of the Diagnostic Potential. | Int J Mol Sci | 2023 | 38003403 | PubTator, text mining | PubMed |
| Research progress of glucocorticoid resistance in chronic rhinosinusitis with nasal polyps: A review. | Medicine (Baltimore) | 2023 | 37986338 | PubTator, text mining | PubMed |
| Role of Exosomal Non-Coding RNA in the Tumour Microenvironment of Genitourinary System Tumours. | Technol Cancer Res Treat | 2023 | 37981789 | PubTator, text mining | PubMed |
| Biomarkers in renal cell carcinoma and their targeted therapies: a review. | Explor Target Antitumor Ther | 2023 | 37970211 | PubTator, text mining | PubMed |
| First trimester prediction models for small-for- gestational age and fetal growth restricted fetuses without the presence of preeclampsia. | Mol Cell Probes | 2023 | 37951512 | PubTator, text mining | PubMed |
| Expression of cAMP and oxidative phosphorylation-related lncRNAs in non-functioning pituitary adenomas. | J Cell Mol Med | 2023 | 37933082 | PubTator, text mining | PubMed |
| Insight into extracellular vesicles in vascular diseases: intercellular communication role and clinical application potential. | Cell Commun Signal | 2023 | 37907962 | PubTator, text mining | PubMed |
| Oncomeric Profiles of microRNAs as New Therapeutic Targets for Treatment of Ewing's Sarcoma: A Composite Review. | Genes (Basel) | 2023 | 37895198 | PubTator, text mining | PubMed |
| RNA Profiles of Tear Fluid Extracellular Vesicles in Patients with Dry Eye-Related Symptoms. | Int J Mol Sci | 2023 | 37895069 | PubTator, text mining | PubMed |
| Mutant p53 Gain-of-Function Induces Migration and Invasion through Overexpression of miR-182-5p in Cancer Cells. | Cells | 2023 | 37887350 | PubTator, text mining | PubMed |
| Relevance of micro-RNAs and their targets as a diagnostic and prognostic marker in oral squamous cell carcinoma. | J Oral Maxillofac Pathol | 2023 | 37854932 | PubTator, text mining | PubMed |
| Unraveling the hypoxia modulating potential of VEGF family genes in pan-cancer. | Genomics Inform | 2023 | 37852616 | PubTator, text mining | PubMed |
| Deciphering the Functional Long Non-Coding RNAs Derived from MicroRNA Loci. | Adv Sci (Weinh) | 2023 | 37849233 | PubTator, text mining | PubMed |
| p63: a crucial player in epithelial stemness regulation. | Oncogene | 2023 | 37848625 | PubTator, text mining | PubMed |
| The multifaceted role of extracellular vesicles in prostate cancer-a review. | Cancer Drug Resist | 2023 | 37842237 | PubTator, text mining | PubMed |
| The role and impact of alternative polyadenylation and miRNA regulation on the expression of the multidrug resistance-associated protein 1 (MRP-1/ABCC1) in epithelial ovarian cancer. | Sci Rep | 2023 | 37838788 | PubTator, text mining | PubMed |
| Epigenetic Biomarkers of Metabolic Responses to Lifestyle Interventions. | Nutrients | 2023 | 37836535 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406920/papers?page=5